Overview Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis Status: Completed Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the efficacy of LAS41005 in comparison to placebo and to LAS106521 in actinic keratosis (AK). Phase: Phase 3 Details Lead Sponsor: Almirall, S.A.